Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.960
+0.010 (0.51%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $49.78 million as of October 2, 2026. Its market cap has decreased by -10.01% in one year.
Market Cap
49.78M
Enterprise Value
30.51M
1-Year Change
-10.01%
Ranking
Category
Stock Price
$1.96
ChartMarket Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $49.78M, a decrease of -60.21%. That is a compound annual growth rate of -30.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 49.78M | 144.04% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 54.81M |
| ImageneBio | 53.69M |
| Edesa Biotech | 52.83M |
| Apollomics | 52.55M |
| Dogwood Therapeutics | 51.76M |
| Celularity | 50.95M |
| BioStem Technologies | 50.69M |
| Filana Therapeutics | 49.76M |